Business
Eiko Lifesciences Limited Press Release Aug 12 2026
Pursuant to the Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and amendments thereto, this is to inform that the Meeting of the Board of Directors of the Company held today i.e., on Wednesday, 12th August, 2026, which commenced at 1:00 PM, and concluded at 01:40 PM, Board, inter-alia, approved and taken on record the following:1. Approved Un-Audited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2026 along with Limited Review Report issued by the Statutory Auditors of the Company.
About this update from Eiko Lifesciences Limited
Pursuant to the Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and amendments thereto, this is to inform that the Meeting of the Board of Directors of the Company held today i.e., on Wednesday, 12th August, 2026, which commenced at 1:00 PM, and concluded at 01:40 PM, Board, inter-alia, approved and taken on record the following:1. Approved Un-Audited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2026 along with Limited Review Report issued by the Statutory Auditors of the Company. View Attachment
View stock analysis, news, and events for Eiko Lifesciences Limited